Search

everythinglearnresearchcommunity

for

Search:↓

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Korean psoriasis patients still use alternative medicine despite effective biologics.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

European dermatologic treatments focus on lifestyle and psychosocial factors, use diverse methods like baths and climate therapy, and emphasize the importance of diet and supplements for skin health.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Baricitinib is the most effective treatment for alopecia areata.

Exosomes show promise as effective treatments for autoimmune skin diseases with fewer side effects.

Nanoparticle systems make cancer treatment less toxic.

Co-trimoxazole may help treat autoimmune diseases.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Baricitinib works better than methotrexate for severe alopecia areata.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

Microsponges delivery system is a safe, versatile method for controlled drug release in various treatments.

Taking vitamins, minerals, and amino acids can improve hair strength and quality in people with Monilethrix.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Future alopecia treatments will improve with targeted therapies and personalized approaches.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Herbal treatments may effectively manage hair disorders with fewer side effects than conventional therapies.

Compounded topical preparations should be used with caution for severe psoriasis and generally come after systemic treatments.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.